323 related articles for article (PubMed ID: 19563860)
1. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
[TBL] [Abstract][Full Text] [Related]
2. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of cadmium and arsenic interactions.
Nordberg GF; Jin T; Hong F; Zhang A; Buchet JP; Bernard A
Toxicol Appl Pharmacol; 2005 Aug; 206(2):191-7. PubMed ID: 15967208
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China.
Nordberg GF
Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908
[TBL] [Abstract][Full Text] [Related]
5. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
Chen L; Jin T; Huang B; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium.
Lu J; Jin T; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2005 Aug; 206(2):150-6. PubMed ID: 15967203
[TBL] [Abstract][Full Text] [Related]
8. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
Hong F; Jin TY; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
[TBL] [Abstract][Full Text] [Related]
9. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China.
Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M
Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
Chang X; Jin T; Chen L; Nordberg M; Lei L
Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
[TBL] [Abstract][Full Text] [Related]
11. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population.
Chen L; Lei L; Jin T; Nordberg M; Nordberg GF
Diabetes Care; 2006 Dec; 29(12):2682-7. PubMed ID: 17130205
[TBL] [Abstract][Full Text] [Related]
12. [Cadmium toxicity: summary of personal studies].
Lauwerys R; Buchet JP; Roels H; Bernard A
Toxicol Eur Res; 1982 Jan; 4(1):7-17. PubMed ID: 7051422
[TBL] [Abstract][Full Text] [Related]
13. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of cadmium toxicity in a Thai population with high-level environmental exposure.
Teeyakasem W; Nishijo M; Honda R; Satarug S; Swaddiwudhipong W; Ruangyuttikarn W
Toxicol Lett; 2007 Mar; 169(3):185-95. PubMed ID: 17306939
[TBL] [Abstract][Full Text] [Related]
15. [Renal dysfunction in workers exposed to arsenic and cadmium].
Hong F; Jin TY; Lu GD; Yin ZY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355
[TBL] [Abstract][Full Text] [Related]
16. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of low-level cadmium and arsenic on the kidney.
Huang M; Choi SJ; Kim DW; Kim NY; Park CH; Yu SD; Kim DS; Park KS; Song JS; Kim H; Choi BS; Yu IJ; Park JD
J Toxicol Environ Health A; 2009; 72(21-22):1493-8. PubMed ID: 20077223
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose cadmium exposure on biological examinations.
Nakadaira H; Nishi S
Sci Total Environ; 2003 Jun; 308(1-3):49-62. PubMed ID: 12738200
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan.
Suwazono Y; Kobayashi E; Okubo Y; Nogawa K; Kido T; Nakagawa H
Environ Res; 2000 Sep; 84(1):44-55. PubMed ID: 10991781
[TBL] [Abstract][Full Text] [Related]
20. The effects of low environmental cadmium exposure on bone density.
Trzcinka-Ochocka M; Jakubowski M; Szymczak W; Janasik B; Brodzka R
Environ Res; 2010 Apr; 110(3):286-93. PubMed ID: 20106473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
